HMGB1 and type 1 diabetes mellitus: The upregulation of circulating HMGB1 in patients with T1DM leads to the instability of T regulatory cells, suggesting that blocking HMGB1 may be an effective therapeutic approach for T1DM (Zhang et al. 2020).